New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- 8755 Ash Street, Suite 1
- Vancouver BC, V6P 6T3
Kinexus is striving to be a world leader in development and application of proteomics and bioinformatics for the discovery of novel diagnostics and therapeutics based on leading-edge knowledge of cellular communication systems. To this end, we have created a unique business model where our clients are also our valued partners in the common pursuit of knowledge for the betterment of human health.